Trials / Active Not Recruiting
Active Not RecruitingNCT06719635
Management Modalities of Chronic Pelvic Pain
Laparoscopic Presacral Neurectomy Versus Fluoroscopically Guided Superior Hypogastric Plexus Neurolysis for Treatment of Chronic Pelvic Pain: A Double-Blind, Randomized Controlled Trial.
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Zagazig University · Other Government
- Sex
- Female
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Chronic pelvic pain remains a challenging disorder to treat because of the complexities of pain sensation and unclear etiology. Standard medical and surgical treatments seldom prove effective at improving quality of life and pain intensity among affected women.
Detailed description
Chronic pelvic pain remains a challenging disorder to treat because of the complexities of pain sensation and unclear etiology. Standard medical and surgical treatments seldom prove effective at improving quality of life and pain intensity among affected women. The current study will investigate whether Laparoscopic Presacral Neurectomy or Fluoroscopically Guided Superior Hypogastric Plexus Neurolysis is more effective for treating chronic pelvic pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laparoscopic Presacral Neurectomy | Laparoscopy will be performed under general anesthesia. Then, nerve plexuses will be identified and freed from their underlying tissue, which contains the left common iliac and middle sacral veins. This will be followed by cauterization and cutting of the nerve plexuses. |
| PROCEDURE | Fluoroscopically guided Superior Hypogastric Plexus Neurolysis | The patients will receive fluoroscopically guided Superior Hypogastric Plexus Neurolysis using 3 mL of 75% ethanol and Radiofrequency of the Sacral nerve Roots 2-4. |
Timeline
- Start date
- 2024-12-07
- Primary completion
- 2026-01-01
- Completion
- 2026-05-01
- First posted
- 2024-12-06
- Last updated
- 2025-11-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06719635. Inclusion in this directory is not an endorsement.